BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 35804885)

  • 1. Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective.
    Ali SS; Raj R; Kaur T; Weadick B; Nayak D; No M; Protos J; Odom H; Desai K; Persaud AK; Wang J; Govindarajan R
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of transporters in the toxicity of nucleoside and nucleotide analogs.
    Koczor CA; Torres RA; Lewis W
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):665-76. PubMed ID: 22509856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Structural and Molecular Features Involved in the Transport of 3'-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3.
    Rahman MF; Raj R; Govindarajan R
    Drug Metab Dispos; 2018 May; 46(5):600-609. PubMed ID: 29530865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian nucleoside transporters.
    Kong W; Engel K; Wang J
    Curr Drug Metab; 2004 Feb; 5(1):63-84. PubMed ID: 14965251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.
    Zhang J; Visser F; King KM; Baldwin SA; Young JD; Cass CE
    Cancer Metastasis Rev; 2007 Mar; 26(1):85-110. PubMed ID: 17345146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line.
    Crawford CR; Cass CE; Young JD; Belt JA
    Biochem Cell Biol; 1998; 76(5):843-51. PubMed ID: 10353719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition.
    Cano-Soldado P; Pastor-Anglada M
    Med Res Rev; 2012 Mar; 32(2):428-57. PubMed ID: 21287570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity.
    Lu X; Gong S; Monks A; Zaharevitz D; Moscow JA
    J Exp Ther Oncol; 2002; 2(4):200-12. PubMed ID: 12416024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: in vitro toxicity to precursor cells and microstromal environment.
    Luster MI; Germolec DR; White KL; Fuchs BA; Fort MM; Tomaszewski JE; Thompson M; Blair PC; McCay JA; Munson AE
    Toxicol Appl Pharmacol; 1989 Nov; 101(2):328-39. PubMed ID: 2554533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of nucleoside analogs across the plasma membrane: a clue to understanding drug-induced cytotoxicity.
    Huber-Ruano I; Pastor-Anglada M
    Curr Drug Metab; 2009 May; 10(4):347-58. PubMed ID: 19519343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside transporters of mammalian cells.
    Cass CE; Young JD; Baldwin SA; Cabrita MA; Graham KA; Griffiths M; Jennings LL; Mackey JR; Ng AM; Ritzel MW; Vickers MF; Yao SY
    Pharm Biotechnol; 1999; 12():313-52. PubMed ID: 10742981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABC transporters and their role in nucleoside and nucleotide drug resistance.
    Fukuda Y; Schuetz JD
    Biochem Pharmacol; 2012 Apr; 83(8):1073-83. PubMed ID: 22285911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of solute carrier transporters in pancreatic cancer: a review.
    Lemstrová R; Souček P; Melichar B; Mohelnikova-Duchonova B
    Pharmacogenomics; 2014 Jun; 15(8):1133-45. PubMed ID: 25084206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
    Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
    Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney.
    Mangravite LM; Badagnani I; Giacomini KM
    Eur J Pharmacol; 2003 Oct; 479(1-3):269-81. PubMed ID: 14612157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nucleoside transporters in nucleoside-derived drug sensitivity.
    Molina-Arcas M; Pastor-Anglada M
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):335-46. PubMed ID: 20544517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside transport in normal and neoplastic cells.
    Belt JA; Marina NM; Phelps DA; Crawford CR
    Adv Enzyme Regul; 1993; 33():235-52. PubMed ID: 8356910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.
    Anderson JT; Huang KM; Lustberg MB; Sparreboom A; Hu S
    Rev Physiol Biochem Pharmacol; 2022; 183():177-215. PubMed ID: 32761456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.
    Damaraju VL; Damaraju S; Young JD; Baldwin SA; Mackey J; Sawyer MB; Cass CE
    Oncogene; 2003 Oct; 22(47):7524-36. PubMed ID: 14576856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
    Damaraju VL; Smith KM; Mowles D; Nowak I; Karpinski E; Young JD; Robins MJ; Cass CE
    Biochem Pharmacol; 2011 Jan; 81(1):82-90. PubMed ID: 20854794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.